|
1
|
Sandlund JT, Downing JR and Crist WM:
Non-Hodgkin's lymphoma in childhood. N Engl J Med. 334:1238–1248.
1996.
|
|
2
|
Cairo MS, Raetz E, Lim MS, et al:
Childhood and adolescent non-Hodgkin lymphoma: new insights in
biology and critical challenges for the future. Pediatr Blood
Cancer. 45:753–769. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Gross TG and Termuhlen AM: Pediatric
non-Hodgkin's lymphoma. Curr Oncol Rep. 9:459–465. 2007.
|
|
4
|
Hochberg J, Waxman IM, Kelly KM, et al:
Adolescent non-Hodgkin lymphoma and Hodgkin lymphoma: state of the
science. Br J Haematol. 144:24–40. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Brousse N, Vasiliu V, Michon J, et al:
Pediatric non-Hodgkin lymphomas. Ann Pathol. 24:574–586. 2004.(In
French).
|
|
6
|
Setty BA and Termuhlen AM: Rare pediatric
non-Hodgkin lymphoma. Curr Hematol Malig Rep. 5:163–168. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Sharon V, Mecca PS, Steinherz PG, et al:
Two pediatric cases of primary cutaneous B-cell lymphoma and review
of the literature. Pediatr Dermatol. 26:34–39. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Swerdlow SH: Pediatri. follicular
lymphomas, marginal zone lymphomas, and marginal zone hyperplasia.
Am J Clin Pathol. 122 Suppl:S98–S109. 2004.PubMed/NCBI
|
|
9
|
Lones MA, Perkins SL, Sposto R, et al:
Non-Hodgkin lymphoma arising in bone in children and adolescents is
associated with an excellent outcome: a Children's Cancer Group
Report. J Clin Oncol. 20:2293–2301. 2002.PubMed/NCBI
|
|
10
|
Gatta G, Corazziari I, Magnani C,
Peris-Bonet R, Roazzi P and Stiller CEUROCARE Working Group:
Childhood cancer survival in Europe. Ann Oncol. 14 (Suppl
5):v119–v127. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Gross TG and Perkins SL: Malignant
non-Hodgkin's lymphoma in children. Principles and Practice of
Pediatric Oncology. Pizzo PA and Poplack DG: 6th. Lippincott
Williams: Philadelphia: pp. 663–682. 2011
|
|
12
|
Gutierrez MI, Bhatia K, Barriga F, et al:
Molecular epidemiology of Burkitt's lymphoma from South America:
differences in breakpoint location and Epstein-Barr virus
association from tumors in other world regions. Blood.
79:3261–3266. 1992.
|
|
13
|
Jaffe ES, Harris NL, Stein H, et al:
Introduction and overview of the classification of the lymphoid
neoplasms. WHO Classification of Tumours of Haematopoietic and
Lymphoid Tissues. Swerdlow SH, Campo E, Harris NL, Jaffe ES, Pileri
SA, Stein H, Thiele J and Vardiman JW: 4th. IARC Press; Lyon: pp.
157–166. 2008
|
|
14
|
Murphy SB: Classification, staging and end
results of treatment of childhood non-Hodgkin's lymphomas:
dissimilarities from lymphomas in adults. Semin Oncol. 7:332–339.
1980.PubMed/NCBI
|
|
15
|
Ries LAG, Smith MA, Gurney JG, Linet M,
Tamra T, Young JL and Bruin GR: Cance. Incidence and Survival Among
Children and Adolescents: United States SEER Program 1975–1995.
National Cancer Institute, SEER Program; : Bethesda, MD: 1999
|
|
16
|
Pedrosa MF, Pedrosa F, Lins MM, et al:
Non-Hodgkin's lymphoma in childhood: clinical and epidemiological
characteristics and survival analysis at a single center in
Northeast Brazil. J Pediatr (Rio J). 83:547–554. 2007.
|
|
17
|
Sandlund JT, Fonseca T, Leimig T, et al:
Predominance and characteristics of Burkitt lymphoma among children
with non-Hodgkin lymphoma in northeastern Brazil. Leukemia.
11:743–756. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Klumb CE, Schramm MT, De Resende LM, et
al: Treatment of children with B-cell non-Hodgkin's lymphoma in
developing countries: the experience of a single center in Brazil.
J Pediatr Hematol Oncol. 26:462–468. 2004.
|
|
19
|
Manipadam MT, Nair S, Viswabandya A, et
al: Non-Hodgkin lymphoma in childhood and adolescence: frequency
and distribution of immunomorphological types from a tertiary care
center in South India. World J Pediatr. 7:318–325. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Harris NL, Jaffe ES, Diebold J, et al:
Word Health Organization classification of neoplastic disease of
the hematopoietic and lymphoid tissues: report of the Clinical
Advisory Committee meeting-Airlie House, Virginia, November 1997. J
Clin Oncol. 17:3835–3849. 1999.
|
|
21
|
Naresh KN, Agarwal B, Nathwani BN, et al:
Use of the World Health Organization (WHO) classification of
non-Hodgkin's lymphoma in Mumbai, India: a review of 200
consecutive cases by a panel of five expert hematopathologists.
Leuk Lymphoma. 45:1569–1577. 2004.
|
|
22
|
Temmim L, Baker H, Amanguno H, et al:
Clinicopathological features of extranodal lymphomas: Kuwait
experience. Oncology. 67:382–389. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Wright D, McKeever P and Carter R:
Childhood non-Hodgkin lymphomas in the United Kingdom: findings
from the UK Children's Cancer Study Group. J Clin Pathol.
50:128–134. 1997.
|
|
24
|
Burkhardt B, Zimmermann M, Oschlies I, et
al BFM Group: The impact of age and gender on biology, clinical
features and treatment outcome of non-Hodgkin lymphoma in childhood
and adolescence. Br J Haematol. 131:39–49. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Mokhtar N and Khaled H: Lymphoma. 1st.
Aventis Oncol; Cairo: pp. 47–63. pp. 123–134. 2002
|
|
26
|
Srinivas V, Soman CS and Naresh KN: Study
of the distribution of 289 non-Hodgkin lymphomas using the WHO
classification among children and adolescents in India. Med Pediatr
Oncol. 39:40–43. 2002. View
Article : Google Scholar : PubMed/NCBI
|
|
27
|
Magrath IT: African Burkitt's lymphoma.
History, biology, clinical features, and treatment. Am J Pediatr
Hematol Oncol. 13:222–246. 1991.
|
|
28
|
Hwang IG, Yoo KH, Lee SH, et al:
Clinicopathologic features and treatment outcomes in malignant
lymphoma of pediatric and young adult patients in Korea: comparison
of Korean all-ages group and Western younger age group. Clin
Lymphoma Myeloma. 7:580–586. 2007. View Article : Google Scholar
|
|
29
|
Nakagawa A, Nakamura S, Nakamine H, et al:
Pathology review for paediatric non-Hodgkin's lymphoma patients in
Japan; a report from the Japan association of childhood leukemia
study (JACLS). Eur J Cancer. 40:725–733. 2004.
|
|
30
|
Jaffe ES, Harris NL, Stein H and Vardiman
JW: Patholog. and genetics of tumours of haematopoietic and
lymphoid tissues. World Health Organization Classification of
Tumours. 3rd. IARC Press; Lyon: pp. 227–230. 2001;
|
|
31
|
Anderson JR, Armitage JO and Weisenburger
DD: Epidemiology of the non-Hodgkin's lymphomas: distributions of
the major subtypes differ by geographic locations. Non-Hodgkin's
Lymphoma Classification Project. Ann Oncol. 9:717–720. 1998.
|
|
32
|
Patte C: Non-Hodgkin's lymphoma. Eur J
Cancer. 34:359–363. 1998.
|
|
33
|
Boerma EG, van Imhoff GW, Appel IM, et al:
Gender and age-related difference in Burkitt lymphoma -
epidemiological and clinical data from The Netherlands. Eur J
Cancer. 40:2781–2787. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Pinkerton CR: The continuing challenge of
treatment for non-Hodgkin's lymphoma in children. Br J Haematol.
107:220–234. 1999.
|
|
35
|
Perkins SL: Work-up and diagnosis of
pediatric non-Hodkin's lymphomas. Pediatr Dev Pathol. 3:374–390.
2000.
|
|
36
|
Temmim L, Baker H, Al-Jarallah M, et al:
Clinical characteristics and pathological classification of
non-Hodgkin's lymphoma in Kuwait. Results of a collaborative study
with the International Lymphoma Study Group (ILSG). Leuk Lymphoma.
45:1865–1871. 2004.
|
|
37
|
Reiter A, Schrappe M, Parwaresch R, et al:
Non-Hodgkin's lymphomas of childhood and adolescence: results of a
treatment stratified for biologic subtypes and stage - a report of
Berlin-Frankfurt-Münster Group. J Clin Oncol. 13:359–372. 1995.
|
|
38
|
Reiter A, Schrappe M, Ludwig WD, et al:
Intensive ALL-type therapy without local radiotherapy provides a
90% event-free survival for children with T-cell lymphoblastic
lymphoma: a BFM group report. Blood. 95:416–421. 2000.PubMed/NCBI
|
|
39
|
Link MP, Shuster JJ, Donaldson SS, et al:
Treatment of children and young adults with early-stage
non-Hodgkin's lymphoma. N Engl J Med. 337:1259–1266.
1997.PubMed/NCBI
|
|
40
|
Seidemann K, Tiemann M, Schrappe M, et al:
Short-pulse B-non-Hodgkin lymphoma-type chemotherapy is efficacious
treatment for pediatric anaplastic large cell lymphoma: a report of
the Berlin-Frankfurt-Munster Group Trial NHL-BFM 90. Blood.
97:3699–3706. 2001. View Article : Google Scholar
|
|
41
|
Laver JH, Kraveka JM, Hutchison RE, et al:
Advanced-stage large-cell lymphoma in children and adolescents:
results of a randomized trial incorporating intermediate-dose
methotrexate and high-dose cytarabine in the maintenance phase of
the APO regimen: a Pediatric Oncology Group phase III trial. J Clin
Oncol. 23:541–547. 2005. View Article : Google Scholar
|
